A look at Precision Therapeutics’ upcoming catalysts.
Recently announced projected sales of patented Streamway Machines for 2018 that amount to a 900% increase over 2017.
Highly profitable razor / razor blade business model with 80% margins.
Approved in Europe (2017), Canada (2016), and Australia - recent projected sales only include US.
